| |
|
|
|
|
|
|
|||
|
Blood, 2 April 2009, Vol. 113, No. 14, pp. 3190-3197. Prepublished online as a Blood First Edition Paper on February 5, 2009; DOI 10.1182/blood-2008-07-168575.
Submitted July 15, 2008
Interdepartmental Graduate Program in Neuroscience, School of Medicine and Dentistry, University of Rochester, Rochester, NY, United States * Corresponding author; email: bmsegal{at}med.umich.edu.
Mature myeloid cells (macrophages and CD11b+ dendritic cells) form a prominent component of neuroinflammatory infiltrates in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). The mechanism by which these cells are replenished during relapsing and chronic neuroinflammation is poorly understood. Here we demonstrate that CD11b+CD62L+Ly6Chi monocytes with colony forming potential are mobilized into the bloodstream by a GM-CSF dependent pathway immediately prior to EAE relapses. Circulating Ly6Chi monocytes traffic across the blood brain barrier (BBB), upregulate proinflammatory molecules and differentiate into CNS dendritic cells and macrophages. Enrichment of Ly6Chi monocytes in the circulating pool is associated with an earlier onset and increased severity of clinical EAE. Our studies indicate that GM-CSF driven release of Ly6Chi precursors from the bone marrow prevents exhaustion of CNS myeloid populations during relapsing or chronic autoimmune demyelination, suggesting a novel pathway for therapeutic targeting.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||